4.7 Article

Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes

Nancy L. Keating et al.

Summary: This study evaluates the association of the US Centers for Medicare & Medicaid Services Oncology Care Model (OCM), an alternative payment model for cancer patients undergoing chemotherapy, with changes in Medicare spending, utilization, quality, and patient experience during the first 3 years of the OCM (2016-2018). The results show that the OCM was significantly associated with modestly lower Medicare episode payments that did not cover the costs of care coordination or performance-based payments, with no significant differences in most utilization, quality, or patient experience outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients

Emma Boswell Dean et al.

Summary: This study found that practice setting and hospital ownership status were closely associated with the use of biosimilars in the Medicare population, with different patterns observed for different drug classes. Further research is needed to understand the reasons for these differences across drug classes.

JAMA NETWORK OPEN (2021)

Article Oncology

Impact of a G-CSF Policy to Reduce Low-Value Care on Guideline Adherence and Mortality

Chinelo C. Orji et al.

Summary: This study investigated the prevalence and prescribing patterns of G-CSF in patients with metastatic colorectal cancer, as well as the impact of a program initiative on G-CSF prescription patterns, guideline adherence, and mortality. The results showed that the program initiative successfully reduced G-CSF overutilization and improved adherence to guidelines, but did not significantly affect mortality rates.

JCO ONCOLOGY PRACTICE (2021)

Article Oncology

What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy

Eric J. Roeland et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Pharmacology & Pharmacy

Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice

Sandra Cuellar et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)

Article Oncology

Results From a Health Insurer's Clinical Pathway Program in Breast Cancer

Santosh Gautam et al.

JOURNAL OF ONCOLOGY PRACTICE (2018)

Article Oncology

American Society of Clinical Oncology 2013 Top Five List in Oncology

Lowell E. Schnipper et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)